Acoustic neuroma, also known as vestibular schwannoma, is a non-cancerous tumor that develops on the nerve connecting the inner ear to the brain. Symptoms of acoustic neuroma include hearing loss, tinnitus, balance problems, and facial weakness. Treatment options for acoustic neuroma include watchful waiting, surgical removal of tumor, stereotactic radiosurgery, and conventional external beam radiation therapy. The global acoustic neuroma market is primarily driven by the increasing cases of acoustic neuroma disease owing to rising genetic predisposition and environmental factors.
The acoustic neuroma market is estimated to be valued at USD 2.29 Bn in 2024 and is expected to reach USD 4.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9% from 2024 to 2031.
Key Takeaways
Key players operating in the acoustic neuroma market are Amgen, Roche, Natus Medical Incorporated, Elekta, and Pfizer Inc. These players are focusing on developing novel drugs and treatment procedures to increase treatment efficiency and success rates for acoustic neuroma.
The rising prevalence of acoustic neuroma presents significant growth opportunities in the market. According to WHO, approximately 1 in 30,000 people worldwide are diagnosed with acoustic neuroma each year. Moreover, advanced diagnostic techniques are enabling early detection of tumors thereby expanding treatment opportunities.
Globally, North America dominates the Acoustic Neuroma Market owing to high awareness, advanced healthcare infrastructure, and supportive reimbursement policies. However, Asia Pacific is expected to exhibit the highest growth during the forecast period driven by improving accessibility to diagnosis and treatment in countries like China and India.
Market drivers
Aging population prone to age-related hearing loss and ear diseases is a key factor driving the acoustic neuroma market growth. According to the United Nations, the number of people aged 60 years or above is expected to more than double by 2050 and reach nearly 2.1 billion globally. Moreover, rising awareness about diagnosis and treatment availability for the condition through social media and patient support groups is encouraging more patients to seek medical help. This is positively impacting the market revenues.
PEST Analysis
Political: Governments support research and development in healthcare sector which benefits the Acoustic Neuroma market growth. Regulations related to approval of drugs and medical devices are in place which companies need to follow.
Economic: Better access to insurance and rising healthcare budgets across regions drive the patients seeking treatment and thus market demand. Rise in disposable incomes enable affordability of treatments.
Social: Increased medical awareness regarding early symptoms and diagnosis as well as availability of treatment options boosts the market.
Technological: Advancements in imaging technologies aid improved detection rate leading to early stage diagnosis. Development of advanced treatment approaches like stereotactic radiosurgery and microsurgery benefit market growth. Introduction of robot-assisted surgeries provide minimally invasive solutions.
The major geographic regions where the market is concentrated in terms of value currently include North America and Europe. North America alone occupies over 40% market share globally due to robust healthcare infrastructure and availability of advanced treatment options.
The Asia Pacific region is considered to be the fastest growing market for Acoustic Neuroma over the forecast period owing to large patient population, increasing medical tourism, rising disposable incomes, improving access to healthcare and awareness.
Get This Report in Japanese Language: 聴神経腫瘍市場
Get This Report in Korean Language: 음향신경종 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
(https://www.linkedin.com/in/ravina-pandya-1a3984191)
